Table 1.
Statistical data of retinal artery occlusion patients in cardiovascular and thrombophilic risk factors
| Cardiovascular risk factors | Odds ratio | 95% Confidence interval | p |
|---|---|---|---|
| Hypertriglyceridemia | 1.32 | 0.58–2.99 | 0.50 |
| Hypercholesterinemia | 1.66 | 0.73–3.77 | 0.22 |
| Ischemic heart disease | 0.78 | 0.23–2.65 | 0.69 |
| Hypertension | 3.33 | 1.30–9.70 | 0.014 |
| Diabetes mellitus | 1.03 | 0.35–2.97 | 0.95 |
| Current smoking | 0.54 | 0.05–5.03 | 0.59 |
| Thrombophilic risk factors | |||
| Hyperfibrinogenemia | 2.91 | 1.29–6.57 | 0.010 |
| Elevated FVIII | 0.78 | 0.35–1.73 | 0.54 |
| FV ( Leiden) | 3.96 | 1.43–10.96 | 0.008 |
| FII G20210A allel | Not estimated (No cases) | ||
| PC ↓ | Not estimated (1 case) | ||
| PS ↓ | Not estimated (2 cases) | ||
| Antithrombinopathy | Not estimated (2 cases) | ||
| Plasminogen ↓ | 1.12 | 0.26–4.75 | 0.87 |
| Lipoprotein(a) ↑ | 0.82 | 0.33–2.02 | 0.67 |
| Hyperhomocysteinemia | 1.47 | 0.66–3.25 | 0.34 |
Abbreviations: FVIII, factor VIII FV(Leiden), factor V of Leiden mutation; FII G20210A, factor II gene polimorphism, G20210A allele; PC↓, decreased level of proteine C; PS↓, decreased level of proteine S; plasminogen ↓, decreased level of plasminogen; Lipoprotein(a)↑, increased level of lipoprotein(a).